Application 084301
- Type
- ANDA
- Sponsor
- TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DRALZINE | HYDRALAZINE HYDROCHLORIDE | TABLET;ORAL | 25MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A084301-001 | DRALZINE | HYDRALAZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A084301-001 | DRALZINE | 25MG | TABLET / ORAL | Approved before 1982 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | Cadila Pharmaceuticals Limited | 3a7562a8-2f67-4411-ac4a-ab7924193e82 | 2022-12-29 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| hydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | c3797028-c625-4f70-ae69-8a5f6f23f1b8 | 2022-08-09 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 8223c44a-73a9-4da5-a468-d1d8bdb0bbd6 | 2022-05-18 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Radha Pharmaceuticals, Inc. | 149fa857-30ad-451d-b6e2-0000483ccc97 | 2021-03-12 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | ScieGen Pharmaceuticals, Inc. | 500b7f76-5f4e-4e7d-85c3-18b9f66d7504 | 2021-03-04 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Exelan Pharmaceuticals Inc. | 811831f9-a844-463a-874d-fb8407659f0b | 2020-09-04 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 63f388e0-9f3d-4902-990c-9a105aa098ad | 2020-09-01 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | dfd60a79-2a30-41e6-b000-a144730099a8 | 2019-10-01 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 48cf71dd-19dc-4239-9117-ebcf9731a45d | 2019-10-01 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | American Regent, Inc. | 17210abc-58f6-442e-8ff2-7971333c82f6 | 2019-05-06 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Ascend Laboratories, LLC | e7bfec3d-5222-4a26-8f99-6c2a28e14aa6 | 2017-12-28 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | bfbd5960-ae6b-46f5-adfa-e330d7a21dfa | 2017-12-21 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 921c8693-84c2-4313-a2a6-ab3be637d554 | 2016-07-14 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d9892176-d4a6-4edb-92b9-5f56243f3d22 | 2016-06-13 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | ddbbdb09-3202-42d7-bbb0-08331dde2f54 | 2016-02-29 | Warnings, Adverse reactions | HYDRALAZINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.